Your session is about to expire
← Back to Search
Brensocatib for Liver Disease
Study Summary
This trial is comparing how well a new drug is absorbed in people with different levels of liver function.
- Liver Disease
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2021 Phase 3 trial • 406 Patients • NCT04817332Trial Design
Find a Location
Logistics
Participation is compensated
You will be compensated for participating in this trial.
Who is running the clinical trial?
Frequently Asked Questions
Has Brensocatib attained regulatory clearance from the FDA?
"Since this is a Phase 1 trial, only minimal data exists that suggests its safety and efficacy. As such, our team at Power assigned Brensocatib a score of one on the risk scale."
Is there an opportunity for me to partake in this experiment?
"This clinical trial is currently seeking 30 participants with a history of hepatic impairment between the ages 18 and 70. For inclusion, each patient must meet specific criteria including a stable medication regimen, BMI between 18 and 35 kg/m^2, no episodes of illness within 30 days prior to screening or check-in that could alter their disease status as determined by medical history, laboratory evaluations, vital signs measurements, ECG tests and physical examinations administered by the investigator (or designee). Additionally these patients have to be adequately matched in terms of age (+/- 10 years), sex and BMI (+/- 20%) when compared to other subjects enrolled in this"
Are there still open positions for participants in this experiment?
"The trial's recruitment status is currently in progress, per information on clinicaltrials.gov. The initial posting was made on October 4th 2022 and the latest update appeared November 7th of that year."
How many participants have enrolled in this trial so far?
"The sponsor, Insmed Incorporated, is responsible for recruiting 30 patients that meet the study's criteria. These participants will be enrolled across two of the trial sites in Orlando and San Antonio respectively."
Is it possible to partake in this investigation if one is above the age of 30?
"The study is open to patients aged 18-70, while there are 27 trials tailored for those below age of majority and 223 studies designed for people over 65."
Share this study with friends
Copy Link
Messenger